BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26576600)

  • 1. [Enhancing our single molecule experience using Crispr].
    Gaudin R
    Med Sci (Paris); 2015 Nov; 31(11):959-61. PubMed ID: 26576600
    [No Abstract]   [Full Text] [Related]  

  • 2. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new method in biotechnology].
    Hofmann-Aßmus M
    MMW Fortschr Med; 2015 Apr; 157(7):75. PubMed ID: 26012467
    [No Abstract]   [Full Text] [Related]  

  • 5. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Mar; 12(512):666-7. PubMed ID: 27172698
    [No Abstract]   [Full Text] [Related]  

  • 9. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
    Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
    Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
    Liang Z; Zhang K; Chen K; Gao C
    J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure and function of CRISPR-Cas9].
    Nishimasu H
    Seikagaku; 2015 Dec; 87(6):686-92. PubMed ID: 26863746
    [No Abstract]   [Full Text] [Related]  

  • 13. CRISPR-Cas systems for genome engineering and investigation.
    Concordet JP; Giovannangeli C
    Methods; 2017 May; 121-122():1-2. PubMed ID: 28645537
    [No Abstract]   [Full Text] [Related]  

  • 14. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing with CRISPR.
    Gross P
    Nat Genet; 2024 Jun; 56(6):1038. PubMed ID: 38871864
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases].
    Tremblay JP
    Med Sci (Paris); 2015 Nov; 31(11):1014-22. PubMed ID: 26576609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in molecular mechanisms of adaptive immunity mediated by type I-E CRISPR/Cas system--A review].
    Sun D; Qiu J
    Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):1-7. PubMed ID: 27305774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.
    Gori JL; Hsu PD; Maeder ML; Shen S; Welstead GG; Bumcrot D
    Hum Gene Ther; 2015 Jul; 26(7):443-51. PubMed ID: 26068008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.